Defects in 18 S or 28 S RRNA Processing Activate the P53 Pathway

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Jan 9

PMID 20056613

Citations 42

Authors

Michael Holzel

Mathias Orban

Julia Hochstatter

Michaela Rohrmoser

Thomas Harasim

Anastassia Malamoussi

Elisabeth Kremmer

Gernot Langst

Dirk Eick

Affiliations

Soon will be listed here.

Abstract

The p53 tumor suppressor pathway is activated by defective ribosome synthesis. Ribosomal proteins are released from the nucleolus and block human double minute-2 (Hdm2) that targets p53 for degradation. However, it remained elusive how abrogation of individual rRNA processing pathways contributes to p53 stabilization. Here, we show that selective inhibition of 18 S rRNA processing provokes accumulation of p53 as efficiently as abrogated 28 S rRNA maturation. We describe hUTP18 as a novel mammalian rRNA processing factor that is specifically involved in 18 S rRNA production. hUTP18 was essential for the cleavage of the 5'-external transcribed spacer leader sequence from the primary polymerase I transcript, but was dispensable for rRNA transcription. Because maturation of the 28 S rRNA was unaffected in hUTP18-depleted cells, our results suggest that the integrity of both the 18 S and 28 S rRNA synthesis pathways can be monitored independently by the p53 pathway. Interestingly, accumulation of p53 after hUTP18 knock down required the ribosomal protein L11. Therefore, cells survey the maturation of the small and large ribosomal subunits by separate molecular routes, which may merge in an L11-dependent signaling pathway for p53 stabilization.

Citing Articles

Elimination of apoptotic cells by non-professional embryonic phagocytes can be stimulated or inhibited by external stimuli.

Pisko J, cikos S, Spirkova A, Sefcikova Z, Kovarikova V, Fabian D Sci Rep. 2025; 15(1):5494.

PMID: 39953116 PMC: 11828932. DOI: 10.1038/s41598-025-88800-z.

Nucleolar stress: Molecular mechanisms and related human diseases.

Maehama T, Nishio M, Otani J, Mak T, Suzuki A Cancer Sci. 2023; 114(5):2078-2086.

PMID: 36762786 PMC: 10154868. DOI: 10.1111/cas.15755.

Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs.

Liao H, Gaur A, McConie H, Shekar A, Wang K, Chang J Nucleic Acids Res. 2022; 50(18):10695-10716.

PMID: 36161484 PMC: 9561284. DOI: 10.1093/nar/gkac817.

p53 induces a survival transcriptional response after nucleolar stress.

Liao H, Gaur A, Mauvais C, Denicourt C Mol Biol Cell. 2021; 32(20):ar3.

PMID: 34319761 PMC: 8684752. DOI: 10.1091/mbc.E21-05-0251.

, a candidate gene for isolated congenital asplenia, is required for pre-rRNA processing and spleen formation in .

Griffin J, Sondalle S, Robson A, Mis E, Griffin G, Kulkarni S Development. 2018; 145(20).

PMID: 30337486 PMC: 6215398. DOI: 10.1242/dev.166181.

References

Yuan X, Zhou Y, Casanova E, Chai M, Kiss E, Grone H . Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell. 2005; 19(1):77-87. DOI: 10.1016/j.molcel.2005.05.023. View

Houseley J, LaCava J, Tollervey D . RNA-quality control by the exosome. Nat Rev Mol Cell Biol. 2006; 7(7):529-39. DOI: 10.1038/nrm1964. View

Jin A, Itahana K, Okeefe K, Zhang Y . Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol. 2004; 24(17):7669-80. PMC: 506972. DOI: 10.1128/MCB.24.17.7669-7680.2004. View

Sun X, Dai M, Lu H . 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem. 2007; 282(11):8052-9. DOI: 10.1074/jbc.M610621200. View

Rubbi C, Milner J . Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003; 22(22):6068-77. PMC: 275437. DOI: 10.1093/emboj/cdg579. View

Zhu Y, Poyurovsky M, Li Y, Biderman L, Stahl J, Jacq X . Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell. 2009; 35(3):316-26. PMC: 2896961. DOI: 10.1016/j.molcel.2009.07.014. View

Mayer C, Grummt I . Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene. 2006; 25(48):6384-91. DOI: 10.1038/sj.onc.1209883. View

Staub E, Fiziev P, Rosenthal A, Hinzmann B . Insights into the evolution of the nucleolus by an analysis of its protein domain repertoire. Bioessays. 2004; 26(5):567-81. DOI: 10.1002/bies.20032. View

Zhang Y, White Wolf G, Bhat K, Jin A, Allio T, Burkhart W . Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003; 23(23):8902-12. PMC: 262682. DOI: 10.1128/MCB.23.23.8902-8912.2003. View

10.

Holzel M, Rohrmoser M, Schlee M, Grimm T, Harasim T, Malamoussi A . Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J Cell Biol. 2005; 170(3):367-78. PMC: 2171466. DOI: 10.1083/jcb.200501141. View

11.

Pestov D, Strezoska Z, Lau L . Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol. 2001; 21(13):4246-55. PMC: 87085. DOI: 10.1128/MCB.21.13.4246-4255.2001. View

12.

Smith T, Gaitatzes C, Saxena K, Neer E . The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 1999; 24(5):181-5. DOI: 10.1016/s0968-0004(99)01384-5. View

13.

Gallagher J, Dunbar D, Granneman S, Mitchell B, Osheim Y, Beyer A . RNA polymerase I transcription and pre-rRNA processing are linked by specific SSU processome components. Genes Dev. 2004; 18(20):2506-17. PMC: 529538. DOI: 10.1101/gad.1226604. View

14.

Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn E . Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene. 2007; 26(35):5029-37. DOI: 10.1038/sj.onc.1210327. View

15.

Harris S, Levine A . The p53 pathway: positive and negative feedback loops. Oncogene. 2005; 24(17):2899-908. DOI: 10.1038/sj.onc.1208615. View

16.

Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, Hall J . Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol. 2009; 11(4):501-8. PMC: 4810440. DOI: 10.1038/ncb1858. View

17.

Dragon F, Gallagher J, Mitchell B, Porwancher K, Wehner K, Wormsley S . A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature. 2002; 417(6892):967-70. PMC: 11487672. DOI: 10.1038/nature00769. View

18.

Dai M, Lu H . Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem. 2004; 279(43):44475-82. DOI: 10.1074/jbc.M403722200. View

19.

Lohrum M, Ludwig R, Kubbutat M, Hanlon M, Vousden K . Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell. 2003; 3(6):577-87. DOI: 10.1016/s1535-6108(03)00134-x. View

20.

Grimm T, Holzel M, Rohrmoser M, Harasim T, Malamoussi A, Gruber-Eber A . Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell proliferation via incorporation into the PeBoW-complex. Nucleic Acids Res. 2006; 34(10):3030-43. PMC: 1474060. DOI: 10.1093/nar/gkl378. View